Are Biosimilar Drugs Similar Enough to Switch From Biologics? Are Biosimilar Drugs Similar Enough to Switch From Biologics?

The US Food and Drug Administration says biosimilars are as safe and effective as the biologics, and doctors agree ― but they are cautious about changing the treatment regimen of patients doing well.Kaiser Health News
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Hematology-Oncology News Source Type: news